Viral infection switches non-plasmacytoid dendritic cells into high interferon producers

被引:464
作者
Diebold, SS
Montoya, M
Unger, H
Alexopoulou, L
Roy, P
Haswell, LE
Al-Shamkhani, A
Flavell, R
Borrow, P
Sousa, CRE [1 ]
机构
[1] Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England
[2] Edward Jenner Inst Vaccine Res, Compton RG20 7NN, Berks, England
[3] Univ Vet Med, Inst Virol, A-1210 Vienna, Austria
[4] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[5] Howard Hughes Med Inst, New Haven, CT 06520 USA
[6] London Sch Hyg & Trop Med, London WC1A 7HT, England
[7] Southampton Gen Hosp, Sch Med, Canc Sci Div, Tenovus Res Lab, Southampton SO16 6YD, Hants, England
基金
英国惠康基金;
关键词
Viral infection;
D O I
10.1038/nature01783
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type I interferons (IFN-I) are important cytokines linking innate and adaptive immunity(1). Plasmacytoid dendritic cells make high levels of IFN-I in response to viral infection and are thought to be the major source of the cytokines in vivo(2). Here, we show that conventional non-plasmacytoid dendritic cells taken from mice infected with a dendritic-cell-tropic strain of lymphocytic choriomeningitis virus make similarly high levels of IFN-I on subsequent culture. Similarly, non-plasmacytoid dendritic cells secrete high levels of IFN-I in response to double-stranded RNA (dsRNA), a major viral signature(3), when the latter is introduced into the cytoplasm to mimic direct viral infection. This response is partially dependent on the cytosolic dsRNA-binding enzyme protein kinase R-4 and does not require signalling through toll-like receptor (TLR) 3, a surface receptor for dsRNA(5). Furthermore, we show that sequestration of dsRNA by viral NS1 (refs 6,7) explains the inability of conventional dendritic cells to produce IFN-I on infection with influenza. Our results suggest that multiple dendritic cell types, not just plasmacytoid cells, can act as specialized interferon-producing cells in certain viral infections, and reveal the existence of a TLR-independent pathway for dendritic cell activation that can be the target of viral interference.
引用
收藏
页码:324 / 328
页数:5
相关论文
共 31 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology [J].
Asselin-Paturel, C ;
Boonstra, A ;
Dalod, M ;
Durand, I ;
Yessaad, N ;
Dezutter-Dambuyant, C ;
Vicari, A ;
O'Garra, A ;
Biron, C ;
Brière, F ;
Trinchieri, G .
NATURE IMMUNOLOGY, 2001, 2 (12) :1144-1150
[4]   Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection [J].
Balachandran, S ;
Roberts, PC ;
Brown, LE ;
Truong, H ;
Pattnaik, AK ;
Archer, DR ;
Barber, GN .
IMMUNITY, 2000, 13 (01) :129-141
[5]   Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication [J].
Bergmann, M ;
Garcia-Sastre, A ;
Carnero, E ;
Pehamberger, H ;
Wolff, K ;
Palese, P ;
Muster, T .
JOURNAL OF VIROLOGY, 2000, 74 (13) :6203-6206
[6]   VIRUS-INDUCED IMMUNOSUPPRESSION - IMMUNE SYSTEM-MEDIATED DESTRUCTION OF VIRUS-INFECTED DENDRITIC CELLS RESULTS IN GENERALIZED IMMUNE SUPPRESSION [J].
BORROW, P ;
EVANS, CF ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1995, 69 (02) :1059-1070
[7]  
Bruno L, 2001, EUR J IMMUNOL, V31, P3403, DOI 10.1002/1521-4141(200111)31:11<3403::AID-IMMU3403>3.0.CO
[8]  
2-T
[9]   Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon [J].
Cella, M ;
Jarrossay, D ;
Facchetti, F ;
Alebardi, O ;
Nakajima, H ;
Lanzavecchia, A ;
Colonna, M .
NATURE MEDICINE, 1999, 5 (08) :919-923
[10]   Interferon-producing cells: on the front line in immune responses against pathogens [J].
Colonna, M ;
Krug, A ;
Cella, M .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (03) :373-379